Search

Your search keyword '"Priceman, Saul J."' showing total 228 results

Search Constraints

Start Over You searched for: Author "Priceman, Saul J." Remove constraint Author: "Priceman, Saul J."
228 results on '"Priceman, Saul J."'

Search Results

1. PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

3. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

4. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy

7. Contributors

11. Author response: Regulation of nuclear transcription by mitochondrial RNA in endothelial cells

12. Hyperthermic Intraperitoneal Chemotherapy–Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer

13. CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

14. Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression

18. Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

21. Abstract 4090: Regional administration of IL-12 endowed CAR T cells effectively targets systemic disease

22. Supplementary Figures from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

28. Figure S1 from Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity

29. Figure S1, Figure S2, Figure S3, Figure S4 from Regional Delivery of Chimeric Antigen Receptor–Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain

30. Supplementary Materials and Methods from Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer

31. Supplemental Figure 6 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

32. Data from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

33. Supplementary Figures 1-5 from The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

34. Supplemental Figure 4 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

35. Supplemental Figure 2 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

36. Supplemental Figure Legends from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

37. Supplemental Figure 3 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

38. Supplemental Figure 1 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

41. Supplemental Figure 5 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

43. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

44. Regulation of Nuclear Transcription by Mitochondrial RNA

48. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages

49. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell therapy

Catalog

Books, media, physical & digital resources